Sliced Bread - Series 17: Experimental Peptides
Summary
This episode of Sliced Bread investigates the trend of unregulated experimental peptides, such as the "Wolverine Stack," marketed for healing and anti-aging. Host Greg Foot and longevity expert Dr. Andrew Steele examine the scant scientific evidence, noting that most data comes from animal studies or tiny, flawed human trials. The discussion highlights significant risks, including contamination, incorrect dosing, and potential cancer acceleration, concluding that current claims are largely marketing hype rather than proven medical benefits.
Topics discussed
Introduction: Listeners suggest investigating peptides
Expert intro: What are peptides and the regulatory gray area
The Wolverine Stack: BPC-157 claims and lack of human trials
TB-500 and GHK-Cu: The Glow Stack and combination risks
KP-1 peptide and the 'research only' loophole
Regulation: MHRA stance on borderline products
Safety risks: Purity, dosage, and injection hazards
Long-term risks: Potential for accelerating cancer growth
Verdict: Marketing BS and final thoughts
Listen ad-free on Castria